8-K//Current report
Aclaris Therapeutics, Inc. 8-K
Accession 0001558370-25-008430
$ACRSCIK 0001557746operating
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 4:01 PM ET
Size
599.0 KB
Accession
0001558370-25-008430
Documents
- 8-Kacrs-20250605x8k.htmPrimary
8-K
- EX-3.1acrs-20250605xex3d1.htm
EX-3.1
- EX-10.1acrs-20250605xex10d1.htm
EX-10.1
- EX-10.2acrs-20250605xex10d2.htm
EX-10.2
- EX-10.3acrs-20250605xex10d3.htm
EX-10.3
- EX-101.SCHacrs-20250605.xsd
EX-101.SCH
- EX-101.LABacrs-20250605_lab.xml
EX-101.LAB
- EX-101.PREacrs-20250605_pre.xml
EX-101.PRE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001558370-25-008430-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLacrs-20250605x8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Aclaris Therapeutics, Inc.
CIK 0001557746
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001557746
Filing Metadata
- Form type
- 8-K
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 4:01 PM ET
- Size
- 599.0 KB